Aurélie Poncin

发表

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine

P. Delvenne, E. Hendrick, V. Bours, 2018, British Journal of Cancer.

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment

V. Bours, G. Jerusalem, C. Josse, 2018, Oncotarget.

Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites

V. Bours, G. Jerusalem, L. Mutesa, 2021, Scientific Reports.

Immunity and Breast Cancer: Focus on Eosinophils

V. Bours, G. Jerusalem, C. Josse, 2021, Biomedicines.

Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients

V. Bours, G. Jerusalem, C. Oury, 2018, BMC Cancer.

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine

P. Delvenne, E. Hendrick, V. Bours, 2018, British Journal of Cancer.

Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients

V. Bours, G. Jerusalem, C. Oury, 2018, BMC Cancer.

Oncological patients' reactions to COVID‐19 pandemic: A single institution prospective study

A. Rorive, G. Jerusalem, B. Sautois, 2021, Cancer reports.